Vivimed Labs has informed that The Management Committee of the Board of Directors of the Company at its meeting held on March 22, 2013, has allotted 21,26,984 Equity Shares of Rs. 10 each fully paid up at a premium of Rs. 305 per share to NYLIM Jacob Ballas India FUND lll, LLC (Address. IFS Court, Twentyeight, Cybercity, Ebene, Mauritius) against conversion of 6,70,000 CCPS (face value Rs. 1000 each) held by them.
With the allotment of the above shares, the Equity base of the Company stands increased from present level of 139,33,942 to 160,60,926 Equity shares of Rs. 10 each.
The above information is a part of company’s filings submitted to BSE.
